Odds & Ends: Cramer in the Spotlight

Long Jim, Short Jim ETFs began trading amid a handful of launches and closures.

ron
Ron Day
|
Reviewed by: Ron Day
,
Edited by: Ron Day

CNBC’s Jim Cramer took the spotlight this week when a pair of exchange-traded funds that bet on the success or failure of the “Mad Money” host’s stock picks began trading March 2. 

Tuttle Capital Management’s SJIM (Inverse Cramer ETF) and the LJIM (Long Cramer ETF) base their holdings on the opinions shared on his hit show “Mad Money.” From a volume perspective, SJIM crushed LJIM: 30 times the number of SJIM shares were purchased than LJIM as of midafternoon March 3. Still, LJIM eked out a small gain for two days while SJIM gained the first day and fell the next. 

The past week also saw a variety of fund launches, closures and other news. 

Launches 

The following funds launched this week:  

Closures  

The following funds will cease to trade after today, March 3: 

Meanwhile, the iShares iBonds Mar 2023 Term Corporate ex-Financials ETF (IBCE) will cease to trade after March 31 as it hits its maturity date, and the PSYK ETF (PSYK) will do the same as of March 28.

State Street Global Advisors is set to close a trio of ESG bond ETFs. The following funds will see their last day of trading as of April 11:

Invesco has also rescheduled the shutdowns of four of its PureBeta ETFs, which were originally supposed to close at the end of the first quarter. The following ETFs will see their last day of trading on June 23:

Other Changes 

 The International Drawdown Managed Equity ETF (IDME) will change its name to the Aptus International Enhanced Yield ETF and its ticker will change to IDUB.  

 

Contact Ron Day at [email protected] or follow him on Twitter at @RonDayETF    

Ron Day

Ron Day is deputy managing editor at etf.com. He covered business and financial news at Bloomberg News for 20 years, was senior editor at ESG news outlet Karma Impact, and covered general news at several New Jersey daily papers. Day's freelance work has been published in AARP.com, Investopedia.com and BigThink.com.